High Times Presents: The U.S. Cannabis Cup

legalization

Cannabis Has Been Studied More Than Many FDA Approved Pharmaceuticals

Opponents of legalizing cannabis for medicinal purposes are fond of arguing that the plant must be subjected to the same standards of clinical study and FDA review as conventional medicines. What they fail to mention is that cannabis and its active components have already...

Colorado Establishes Mandatory Testing for Edibles, Topicals

All cannabis products sold in Colorado will be forced under the microscope later this year, as state marijuana regulators have established guidelines mandating the use of laboratory testing.

Poll: US Majority Favors Legalization

CBS News released their first ever poll to show nationwide majority support for legalization. Fifty-one percent of those surveyed by CBS said the use of marijuana should be legal, up from 45% who supported legalization in their poll last April.  In October of 2011, C...

The Clinic: Pot is Healthful, Not Harmful

Although, while the President's move to evolve on the marijuana issue certainly helps the cause, it's still hard to stomach hearing him say cannabis is “not very different” from tobacco cigarettes. Because right off the top of my head, I can think of a...

Only Legalization Will End the War on Drugs

The War on Drugs cannot end until the use of drugs is no longer a crime. And there is hope it is ending, as President Obama has directed the Justice Department to allow legalization in Colorado and Washington to move forward. In a widely-quoted interview this weekend, the...

Pages

Notice

Important notice for Seattle US Cannabis Cup attendees.
A company calling itself High Times Travel LLC (hightimestravel.com) has illegally infringed on the HIGH TIMES trademark to sell travel packages for the upcoming US Cup in Seattle.

This company is not affiliated with HIGH TIMES Magazine in any way. If you have purchased a travel package from High Times Travel LLC please contact HIGH TIMES immediately by emailing us at travelcomplaint@hightimes.com